Ceci est une version HTML d'une pièce jointe de la demande d'accès à l'information 'Industry, vaccines and patents (DG SANTE)'.


From:
To:
@efpia.eu
Cc:
 (EMA); 



(SANTE); 
@efpia.eu
Subject:
Letter on packaging and labelling flexibilities for COVID-19 therapeutics
Date:
11 January 2021 09:18:32
Attachments:
image001.png
Our reference: sante.ddg1.b.5(2021)198389
 
Dear Mr 
,
 
Thank you for your letter dated 9 December 2020 on packaging and labelling flexibilities for
COVID-19 therapeutics, requesting that those regulatory flexibilities granted for COVID-19
vaccines across the EU (and detailed in the Q&As on labelling flexibilities for COVID-19 vaccines
published by EMA 27 November 2020) are extended to COVID-19 therapeutics.
 
We would like to inform you that your request is currently being processed and that we are
planning to discuss it with the Agency. We will therefore be in a position to provide you with a
reply as soon as this consultation with EMA is finalised.
 
 
Unit “Medicines: policy, authorisation and monitoring“
 
European Commission
DG Health and Food Safety
_____________
This message represents solely the views of its author and can not be regarded as the official
position of the Commission. It is intended solely for the person to whom it is addressed and may
contain confidential information. If you have received this message in error, please notify me as
soon as possible.